A n increased risk of ischemic heart disease in people born small has been shown in a vast number of studies. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] Because low birth weight could reflect fetal growth restriction, adverse influences in the intrauterine environment such as malnutrition have been proposed to be an explanation for this association. 1, 15 However, given the strong correlation between duration of gestation and birth weight, it is possible that the association between low birth weight and ischemic heart disease may be linked in part to preterm birth. This hypothesis is supported by the fact that associations between preterm birth and common risk factors for ischemic heart disease have been reported in children and young adults. 16 -18 
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Most studies on perinatal risk factors for ischemic heart disease in adult life either lack information on gestational duration or rely on information on gestational duration collected from study subjects themselves several decades after birth. [2] [3] [4] [5] [6] [7] [8] [9] Studies with prospectively recorded data on gestational duration contain only a limited number of subjects in the lower ranges of birth weight and gestational duration. 10 -13,19 We have established a cohort comprising all children born before 35 weeks of gestation and/or with a birth weight Ͻ2000 g (girls) or 2100 g (boys) by manually examining Ϸ250 000 birth records at 4 major delivery units in Sweden during the period of 1925 through 1949. This cohort was then followed up in population-based Swedish registers to disentangle whether the association between low birth weight and ischemic heart disease was due to fetal growth restriction and/or short gestational duration.
The Swedish National Board of Health and Welfare has been responsible for a complete Cause of Death Register since 1952. The board also is responsible for the Hospital Discharge Register. This register collects information on all public inpatient care in Sweden and became nationwide in 1987. Completeness varies with county and diagnosis, but for the diagnosis of acute myocardial infarction, the proportion of false positives and false negatives has been reported to be 5% and 3%, respectively. 20 Since 1960, Statistics Sweden provides annually revised information on name, community, and county of domicile for all residents in Sweden through the Register of Population and Population Changes.
Study Cohort
The source population for this cohort study was all births from 1925 through 1949 at 4 major delivery units in Sweden (Allmänna BB and Södra BB in Stockholm, Uppsala University Hospital, and Sundsvalls County Hospital). Information in birth records was recorded by the attending midwife at time of admission for delivery (maternal age, maternal/paternal occupation, date of last menstrual period, proteinuria or preeclampsia during pregnancy, and proteinuria at time of admission), immediately after delivery (birth weight, birth length, sex, and twin status), or when the mother was discharged from hospital (proteinuria postpartum and breast-feeding at time of discharge). By manually examining the Ϸ250 000 births records during this period, we identified a cohort of infants born preterm, small for gestational age, or both by selecting all newborn infants with a gestational duration of Ͻ35 weeks or a birth weight of Ͻ2000 g for girls and Ͻ2100 g for boys. We chose different cutoff points for girls and boys because boys on average weigh more than girls and we wanted to obtain groups of equal size. Subjects for whom no information was available on gestational duration or for whom only the month for the mother's last menstrual period was given were not included in the cohort. Subjects who emigrated or died before 1987 were excluded.
As a reference cohort, we selected subjects with no history of preterm birth or low birth weight (ie, infants born after 35 weeks of gestation with a birth weight Ͼ2000 g [girls] or 2100 g [boys]). For convenience, we selected the first child of same sex and hospital of birth born after each study subject.
In addition to birth weight and gestational age, we used birth records to collect information on maternal age; maternal/paternal occupation; proteinuria during pregnancy, at admission for delivery, and postpartum; and information on hypertension, twin status, and breast-feeding at time of hospital discharge.
Perinatal Definitions and Categorization
We used last menstrual period to estimate gestational duration, which was categorized into 4 groups: Յ32 completed weeks (very preterm), 33 to 36 weeks (preterm), 37 to 42 weeks (term), and Ն43 weeks (postterm). For mothers who did not recall an exact date of last menstrual period but who could indicate if the last menstrual period was in the beginning, middle, or the end of a given month, we approximated last menstrual period to the 5th, 15th, and 25th of the same month, respectively. If only the month of the last menstrual period was remembered or if it was not recalled at all, the subjects were not included in the cohort. Birth weight was categorized in 7 groups of 500-g intervals from Ͻ1500 to Ն4000 g. To reduce misclassification of pregnancy duration and/or birth weight, we excluded subjects whose birth weight was Ͼ4 SD above or below the mean birth weight for gestational age.
As a measure of fetal growth, we used birth weight for gestational age. We also considered using the ponderal index, which is based on the relation between weight and length. The maximum increase in fetal length occurs in the second trimester, whereas the increase in fetal weight mainly occurs in the third trimester. 21 We had a large proportion of preterm infants in our study, and we considered that using the ponderal index may result in misclassification of growthrestricted preterm infants. In estimating birth weight for gestational age, we could use either the Swedish reference curve for estimated intrauterine fetal growth based on ultrasound estimations of fetal weights in normal pregnancies ending at term 22 or a conventional reference curve based on information on birth weights at different gestational ages. 23 We decided to estimate birth weight for gestational age using fetal growth curves because fetal growth curves will, compared with conventional birth weight standards, probably correctly classify a larger proportion of preterm births as being small for gestational age. Birth weight for gestational age was categorized into 5 groups according to their distance from average in numbers of standard deviations (ՅϪ2, ϾϪ2 to Ϫ1, ϾϪ1 to 0, Ͼ0 to 1, and Ͼ1 SD).
Study subjects were considered exposed to pregnancy-related hypertensive disorders when their mothers met one of the following criteria: proteinuria during pregnancy, several measurements of proteinuria postpartum, or a clinical diagnosis of preeclampsia noted in the birth record. Maternal age was categorized as Յ19, 20 to 36, and Ն37 years.
The socioeconomic status of the family was assessed by the father's or single mother's occupation using 3 categories: high (college education), medium (white-collar workers and farm owners with no college education), and low (blue collar workers and farm hands).
Follow-Up and Analysis
Follow-up started in January 1, 1987, and continued to December 31, 2002 . At the start of follow up, 6801 subjects were in the cohort, 376 of whom were excluded because of a birth weight for gestational age above or below 4 SD from the mean birth weight for gestational duration. We used the Register of Population and Population Changes to ascertain emigration or death during follow-up. Ischemic heart disease was defined from the Cause of Death and the Hospital Discharge Registers using the diagnostic codes 410 to 414 and I20 to I25 according to the 9th and 10th revisions of the International Classification of Disease, respectively.
Because causes of death were available before the start of the Hospital Discharge Registry, we also assessed mortality of ischemic heart disease from 1958 through 1986. We chose 1958 as the starting year of this follow-up because a subset of the cohort was initially created to assess cancer incidence, and 1958 was the starting year for the Swedish Cancer Registry.
Data were modeled through Cox proportional-hazards regression using the TPHREG procedure in SAS Statistical Software, version 9.1 (SAS Institute Inc, Cary, NC). Ischemic heart disease was the failure event, and subjects with no ischemic heart disease were censored at death, emigration, or December 31, 2002, whichever occurred first. Time was modeled from January 1, 1987, to date of event or to date of censoring. We controlled for age at entry in 5-year categories and sex in all analyses by adding these variables in the strata statement. When controlling for birth weight, gestational duration, or fetal growth, we used the same method. Testing for trend was done by scoring categories with equidistant points and using these scores as a continuous variable.
The authors had full access to and take full responsibility for the integrity of the data. All authors have read and agree to the manuscript as written.
Results
Of the 6425 included individuals, 2931 were born preterm (Ͻ37 weeks). Among those born preterm, one third had a gestational duration of Յ32 weeks. In total, 2176 subjects were in the cohort with low birth weight (Ͻ2500 g); of these, 151 had a birth weight of Ͻ1500 g. The distribution of birth weight, gestational duration, and fetal growth is presented in further detail in Table 1 .
During follow-up, 617 subjects either were treated for or died of ischemic heart disease ( Table 2) . When analyzing birth weight and gestational duration separately, we found no significant associations between birth weight or gestational duration and ischemic heart disease (P for trendϭ0.14 and 0.35, respectively) ( Table 2 ). When birth weight was adjusted for gestational duration, a strong negative association with ischemic heart disease emerged (P for trendϭ0.002). Specifically, compared with subjects with a birth weight from 3000 to 3499 g, those with a birth weight of Ͻ1500 g faced, after controlling for gestational age, a 139% increase in risk for ischemic heart disease, whereas the corresponding risk increases among those with a birth weight between 1500 and 2999 g ranged from 29% to 38% (Table 2 ). In contrast, when gestational duration was adjusted for birth weight, we found a significant positive association. Compared with subjects with gestational age between 37 and 42 weeks, those with shorter gestation had, after adjustment for birth weight, a reduced risk of ischemic heart disease ( Table 2) .
Fetal growth, expressed as 1 SD from the mean weight for gestational age according to fetal growth curves, was strongly associated with risk of ischemic heart disease (Table 3) . A birth weight of at least 2 SD below the mean weight for gestational duration was associated with an overall hazard ratio of 1.64 (95% confidence interval, 1.23 to 2.18). We found no evidence that risks were influenced by calendar period of birth. To further assess whether our results were influenced by selective survival, we analyzed the data with the lowest birth weight category (Ͻ1500 g) excluded. Restricting the analysis to subjects with a birth weight of Ն1500 g had no impact on the results (data not shown). We found no association between ischemic heart disease and maternal age, hypertensive diseases during pregnancy, twin status, or breast-feeding at the time of hospital discharge when these variables were stratified on fetal growth (data not shown). Adjusting the analyses for socioeconomic status had no impact on the results, and results were similar regardless of fetal sex (data not shown).
Because birth weight (adjusted for gestational age) and preterm birth (adjusted for birth weight) appeared to have opposite effects on risk of ischemic heart disease, we also investigated whether the effect of fetal growth (in SD) was modified by gestational age. However, we found no evidence that the association between fetal growth and ischemic heart disease was modified by gestational age (Table 4) .
When assessing mortality of ischemic heart disease before 1987, we found 378 deaths in the cohort between 1958 and 1986, and of these, 52 had ischemic heart disease as the underlying cause. Birth weight, gestational duration, and fetal growth were not associated with risk of death from ischemic heart disease before 1987 (data not shown). 
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Discussion
This study is the largest study hitherto conducted on preterm birth, low birth weight, and ischemic heart disease. Moreover, by oversampling subjects who were born preterm and/or were small for gestational age, we were able to evaluate these exposures with considerably greater precision than previous investigations. We found evidence that the association between low birth weight and adult risk of ischemic heart disease was mediated entirely by poor fetal growth.
Our study is population based; information on birth characteristics was based on prospectively collected data; and follow-up was nondifferential through the use of register data. Thus, any differential bias resulting from exposure assessment or case ascertainment is unlikely. One limitation is that study subjects were born between 1925 and 1949, but the follow-up through the Hospital Discharge Registry did not start until 1987. The cohort therefore consists of children born preterm or small for gestational age Ͼ50 years ago who survived beyond childhood. In our cohort, Ϸ65% of subjects born before 33 weeks of gestation had a birth weight for gestational age that was above average. This skewed distribution can be due in part to misclassification of gestational age because the subjects were born up to half a century before ultrasound came into practice. However, another explanation for the skewed distribution in the lowest categories of gestational duration may be selective survival. This is supported by a study on subjects from the same area born during the period 1915 to 1930 that reported a particularly high mortality among children with low birth weight. 11 However, excluding subjects with a birth weight Ͻ1500 g had no impact on the results.
Another limitation of the study is that the follow-up did not cover the entire lifespan of the subjects. For subjects born in 1925, follow-up started at 61 years of age, whereas for subjects born in 1949, it stopped at the age of 53. Although we were able to address mortality in the cohort between 1958 and 1987, the number of deaths during this period was low, and mortality is a less precise measure of disease than morbidity. Because risk estimates were similar regardless of birth period, however, we find it unlikely that this truncated follow-up had any substantial influence on our results.
In this study, we had no or limited information on exposures during pregnancy, including maternal smoking, diabetes mellitus, or hypertensive diseases. Because these exposures may be associated with both fetal growth and ischemic heart disease, this could be a limitation. During the period when most of our subjects were born, however, female smoking was a rare exposure; it was not until the second half of the 1940s that female smoking in Sweden started to increase. 24 This, in combination with our stable risk estimates for successive birth cohorts, makes maternal smoking improbable as an explanation of our findings. Likewise, the lack of an association between pregnancy-related hypertensive disorders and risk of ischemic heart disease argues against any major contribution from maternal preeclampsia to our results. Whether our results would have been modified if we were able to take maternal diabetes mellitus into account cannot be told.
Most [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] but not all 19, 25 studies of birth weight and risk of coronary heart disease find an inverse association, but the strength of the association varies between studies. Our data suggest that the previously reported association between low birth weight and risk of ischemic heart disease is a reflection of growth restriction rather than short gestational age. Such an interpretation is supported by the study of Eriksson et al, 10 who found no association between birth weight and coronary heart disease unless birth weight was adjusted for gestational age, and by the study of Leon et al, 11 who found an association between birth weight and coronary heart disease that disappeared when it was adjusted for birth weight for gestational age. Our data demonstrate associations but cannot establish causality. One explanation for the association between fetal growth restriction and ischemic heart disease could be that fetal malnutrition or undernutrition in the middle to late gestation, as reflected through deviating fetal growth, triggers adaptations in tissues and organs, ultimately resulting in lasting physiological alterations such as insulin resistance, vascular endothelial dysfunction, and deviating neuroendocrine stress responses. 26 -28 This in turn could lead to increased risks of high blood pressure, stroke, non-insulindependent diabetes, and ischemic heart disease in later life, particularly in an affluent postnatal environment. 29 This hypothesis has gained support from a large number of experimental and clinical studies on perinatal characteristics and adulthood diseases. 30, 31 Conflicting data 19, 32 exist, however, and it is unlikely that the association between fetal growth and risk of ischemic heart disease can be attributed to the intrauterine environment alone. As indicated by twin studies, 33 genetic factors also may be involved. In addition, infant nutrition 34, 35 and growth 10,36 contribute significantly and independently of fetal growth to later risk of heart disease.
Other studies have shown that risk factors for cardiovascular disease such as hypertension are more prevalent among children and young adults born preterm than among adults born at term. 16, 18, 37 However, these results come from studies conducted on children having received modern neonatal care, and infant survival has improved substantially during recent decades, particularly among those born very preterm (Ͻ32 weeks of gestation and with birth weights Ͻ1500 g). By contrast, in our cohort of subjects born from 1925 to 1949, we found no association between preterm birth and risk of ischemic heart disease. Whether the discrepant results are due to differences in infant and childhood survival or outcome measurements or gestational age distribution cannot be told, but it emphasizes that caution is called for when the results from our study are generalized to preterm and growthrestricted infants being born today.
Conclusions
In this prospective follow-up study, we have found that fetal growth restriction (ie, birth weight adjusted for gestational age) constitutes a strong perinatal risk factor for ischemic heart disease, whereas neither low birth weight nor short gestational duration per se increases risk. This may explain the inconsistencies in previous studies on the association between low birth weight and risk for cardiovascular disease because many of these studies lack information on gestational duration.
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